文献速递心力衰竭与心肌病

全心舒张末期容积指数指导液体复苏对慢性心衰合并脓毒性休克预后的临床研究

[Clinical study on the effects of global end-diastolic volume index-directed fluid resuscitation on the prognosis of chronic heart failure patients with septic shock].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2019-01-01

该前瞻性随机对照研究纳入41例慢性心衰合并脓毒性休克患者,比较GEDI指导液体复苏与常规早期目标导向治疗的效果。结果显示GEDI组液体负平衡开始时间和机械通气时间均显著短于对照组,ICU病死率及28天病死率两组无显著差异,提示GEDI指导可能改善预后。

要点

  • GEDI指导液体复苏缩短慢性心衰合并脓毒性休克患者的液体负平衡开始时间
  • GEDI指导组机械通气持续时间显著短于常规治疗组
  • 两组ICU病死率及28天病死率差异无统计学意义

核心结论

  • 以容量指标GEDI作为指导对慢性心衰合并脓毒性休克患者进行液体复苏可能改善预后。

研究设计与样本

  • 前瞻性随机对照研究,纳入慢性心衰并脓毒性休克患者41例,对照组21例、试验组20例。
  • 对照组行早期目标导向治疗至CVP达8~12 mmHg、平均动脉压65 mmHg以上、尿量0.5 ml·kg(-1)·h(-1)以上、中心静脉血氧饱和度≥70%。
  • 试验组以脉搏指示连续心输出量监测的GEDI(目标680~800 ml/m(2))指导液体复苏,余复苏目标同对照组。

主要发现

  • 对照组液体负平衡开始时间为3.5(2.5,4.0)d,长于试验组的2.6(2.0,3.0)d(U=115.0,P=0.012)。
  • 对照组机械通气持续时间为355(118,552)h,长于试验组的132(36.75,233.3)h(U=130,P=0.038)。
  • 对照组ICU病死率为38.1%(8/21),试验组为20.0%(4/20),两组差异无统计学意义(χ(2)=1.620,P=0.203)。
  • 对照组28 d病死率为42.9%(9/21),试验组为25.0%(5/20),两组差异无统计学意义(χ(2)=1.482,P=0.477)。

关键数值与推荐

  • GEDI目标范围680~800 ml/m(2)。
  • 对照组CVP目标8~12 mmHg(1 mmHg=0.133 kPa)。
  • 对照组平均动脉压目标65 mmHg以上。
  • 对照组尿量目标0.5 ml·kg(-1)·h(-1)以上。
  • 对照组中心静脉血氧饱和度目标≥70%。

临床怎么用

  • 对慢性心衰合并脓毒性休克患者,可考虑以GEDI指导液体复苏以缩短液体负平衡开始时间和机械通气时间。
  • GEDI指导液体复苏对病死率的影响尚需更大样本研究验证。

局限性

  • 样本量较小(共41例),可能影响病死率等结局的统计效能。
  • 单中心研究设计,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the effect of global end-diastolic volume index (GEDI)-guided fluid resuscitation on the prognosis of patients with chronic heart failure and septic shock. Methods: This study was a prospective randomized controlled study. Consecutive eligible patients were divided into 2 groups according to the random number table method: control group (n=21) and experimental group (n=20). On the basis of routine treatment, patients in the control group received early goal-directed therapy until the central venous pressure (CVP) reaching 8-12 mmHg (1 mmHg=0.133 kPa), mean arterial pressure reaching over 65 mmHg, urine volume reaching over 0.5 ml·kg(-1)·h(-1), and central venous oxygen saturation reaching more than 70%. On the basis of routine treatment, patients in the experimental group were monitored continuously on cardiac output with pulse indication and fluid resuscitation guided by volume index GEDI. The GEDI should be maintained on the range of 680-800 ml/m(2). The remaining resuscitation goals were the same as control group. General clinical data of the two groups were collected at admission. Negative fluid balance onset time, duration of mechanical ventilation, ICU mortality and 28-day mortality were compared between the two groups. The outcomes were recorded as listed: start time of negative fluid balance, duration of mechanical ventilation, mortality in ICU and 28-day mortality. Results: There was no significant difference in age, sex, weight, APACHE Ⅱ score, SOFA score and NYHA functional class score between the two groups (all P>0.05). The negative liquid balance onset time in the control group was 3.5 (2.5, 4.0) days, which was significantly longer than that in the experimental group (2.6 (2.0, 3.0) days,U=115.0, P=0.012). The duration of mechanical ventilation was 355 (118, 552) hours in the control group, which was significantly longer than that in the experimental group (132 (36.75, 233.3) hours, U=130, P=0.038). The ICU mortality was 38.1% (8/21) in the control group, tended to be higher than that in the experimental group (20.0%(4/20), χ(2)=1.620, P=0.203). The 28-day mortality was 42.9% (9/21) in the control group, similar as in the experimental group (25.0%(5/20), χ(2)=1.482,P=0.477). Conclusion: Fluid resuscitation guided by volume index (GEDI) may improve the prognosis of patients with chronic heart failure complicated with septic shock. 目的: 探讨全心舒张末期容积指数(GEDI)指导下的液体复苏对慢性心力衰竭(心衰)合并脓毒性休克患者预后的影响。 方法: 该研究为前瞻性随机对照研究。纳入慢性心衰并脓毒性休克患者共41例,按随机数表法将入选者分为2组,即对照组(n=21)和试验组(n=20)。对照组患者在常规治疗的基础上行早期目标导向治疗至压力指标中心静脉压(CVP)达8~12 mmHg(1 mmHg=0.133 kPa)、平均动脉压65 mmHg以上、尿量0.5 ml·kg(-1)·h(-1)以上、中心静脉血氧饱和度≥70%;试验组在常规治疗的基础上进行脉搏指示连续心输出量监测,以容量指标GEDI为指导进行液体复苏,使GEDI达680~800 ml/m(2),余复苏目标同对照组。收集两组患者入院时的一般临床资料。观察两组患者液体负平衡开始时间、机械通气时间、重症监护室(ICU)病死率及28 d病死率。 结果: (1)一般临床资料:对照组与试验组患者的年龄、性别、体重、急性生理与慢性健康状况评分Ⅱ(APACHE Ⅱ)、序贯脏器衰竭评分(SOFA)、既往纽约心脏协会(NYHA)心功能分级、导致脓毒性休克的感染类型等差异均无统计学意义(P均>0.05)。(2)液体负平衡开始时间:对照组患者液体负平衡开始时间为3.5(2.5,4.0)d明显长于试验组的2.6(2.0,3.0)d(U=115.0,P=0.012)。(3)机械通气持续时间:对照组患者机械通气持续时间为355(118,552)h明显长于试验组的132(37,233)h(U=130,P=0.038)。(4)ICU病死率及28 d病死率:对照组患者ICU病死率为38.1%(8/21),试验组为20.0%(4/20),两组间差异无统计学意义(χ(2)=1.620,P=0.203)。对照组患者28 d病死率为42.9%(9/21),试验组为25.0%(5/20),两组间差异亦无统计学意义(χ(2)=1.482,P=0.477)。 结论: 以容量指标GEDI作为指导对慢性心衰合并脓毒性休克的患者进行液体复苏可能改善预后。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Lin LQ, Liang DC, Jin GY, et al. [Clinical study on the effects of global end-diastolic volume index-directed fluid resuscitation on the prognosis of chronic heart failure patients with septic shock]. Zhonghua Xin Xue Guan Bing Za Zhi. 2019. PMID: 31550844. doi:10.3760/cma.j.issn.0253-3758.2019.09.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。